Clinical trial · Observational
Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia
Description the Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia : Prospective Descriptive Non-comparative Cohort ( QUALI Cohort)
NCT03743961CI-TRIAL-00045826QUALIterminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Low rythm of inclusions
Summary
Brief summary (as posted)
The aim of this study is to describe the impact of : Geriatric intervention contribution on quality of life of elderly patients receiving systemic treatments for metastatic neoplasia
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Elderly Patients | — | UNRESOLVED | — |
| Metastatic Neoplasia | Neoplasm | CURATED_BROADER | 0.78 |
| Systemic Treatment | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| geriatric intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Group A : control group
- description
- Evaluation of quality of life with the EORTC QoL ELD 14 (Quality Qf Life ELDerly patients with 14 Questions) and QoL EORTC Q30 (Quality Qf Life with 30 Questions) for patients with G8 score \> 14/17
- label
- Group B : geriatric intervention group
- description
- Evaluation of quality of life with the EORTC QoL ELD 14 (Quality Qf Life ELDerly patients) and QoL (Quality Qf Life) EORTC Q30 for patients with G8 score ≤14/17 ( in this arm there is two groups : patient who received geriatric intervention before treatment initiation (group A) and group of patient did not received geriatric intervention before treatment initiation( group B))
- interventionNames
- Other: geriatric intervention
Primary outcomes (2)
- measure
- Level of quality of life
- timeFrame
- 6 months
- description
- Level of quality of life will be measured with the QoL ELD 14 (Quality Qf Life ELDerly patients with 14 Questions)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Patient with solid metastatic neoplasia * 75 years old or more * Men or women * ECOG between 0 and 3 * Patient receiving systemic antineoplasic treatment (chemotherapy, hormonotherapy, immunotherapy, targeted therapy) Exclusion Criteria: * ECOG 4 * Localized cancer * Patients already included in a study witch could modify quality of life * Patient unable to give their consent
References
Publications (0)
Data not yet available
No reference posted for this study.